Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: Anti-diabetic agents and the risks of dementia in patients with type 2 diabetes: a systematic review and network meta-analysis of observational studies and randomized controlled trials

Fig. 2

Network plots for observational studies (evaluating the risks of dementia). *Abbreviations: PBO, placebo; MET, metformin; TZD, thiazolidinediones; SU, sulfonylureas; AGI, α-glucosidase inhibitor; DPP-4i, dipeptidyl peptidse-4 inhibitor; SGLT-2i, sodium-glucose cotransporter-2 inhibitor; GLP-1RA, glucagon-like peptide-1 receptor agonist; GKA, glucokinase activator.

Back to article page